ChiCTR1900025747 版本V1.0 版本创建时间2020/04/25 08:56:08 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR1900025747 

最近更新日期:

Date of Last Refreshed on:

2019-09-07 10:30:23 

注册时间:

Date of Registration:

2019-09-07 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

高宇晨医师:该研究的伦理审批文件未上传,请尽快上传。 精准心脏麻醉方案和术后管理策略对成人心血管手术后肺炎的影响

Public title:

The effect of precision cardiac anesthesia and postoperative management on pneumonia after cardiovascular surgery in adults

注册题目简写:

English Acronym:

研究课题的正式科学名称:

精准心脏麻醉方案和术后管理策略对成人心血管手术后肺炎的影响

Scientific title:

The effect of precision cardiac anesthesia and postoperative management on pneumonia after cardiovascular surgery in adults

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

高宇晨 

研究负责人:

王越夫 

Applicant:

Yuchen Gao 

Study leader:

Yuefu Wang 

申请注册联系人电话:

Applicant telephone:

+86 18811581300

研究负责人电话:

Study leader's telephone:

+86 13811491035

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

CMU_LG@163.com

研究负责人电子邮件:

Study leader's E-mail:

wangyuefu@hotmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市西城区北礼士路167号

研究负责人通讯地址:

北京市西城区北礼士路167号

Applicant address:

167 Beiishi Road, Xicheng District, Beijing, China

Study leader's address:

167 Beilishi Road, Xicheng District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

100037

研究负责人邮政编码:

Study leader's postcode:

100037

申请人所在单位:

中国医学科学院阜外医院

Applicant's institution:

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

研究负责人所在单位:

中国医学科学院阜外医院

Affiliation of the Leader:

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2019-1215

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

中国医学科学院阜外医院伦理委员会

Name of the ethic committee:

Ethics Committee of Fuwai Hospital, Chinese Academy of Medical Sciences

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

赵志晶

Contact Name of the ethic committee:

Zhijing Zhao

伦理委员会联系地址:

北京市西城区北礼士路167号

Contact Address of the ethic committee:

167 Beilishi Road, Xicheng District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 010 88396281

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国医学科学院阜外医院

Primary sponsor:

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

研究实施负责(组长)单位地址:

北京市西城区北礼士路167号

Primary sponsor's address:

167 Beilishi Road, Xicheng District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

西城区

Country:

China

Province:

Beijing

City:

Xicheng District

单位(医院):

中国医学科学院阜外医院

具体地址:

北礼士路167号

Institution
hospital:

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Address:

167 Beilishi Road, Xicheng District

经费或物资来源:

医院经费

Source(s) of funding:

Hospital Funds

Target disease:

Postoperative pneumonia

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1) 研究精准心脏麻醉方案对成人心血管手术后肺炎发生的影响; 2) 研究精准心脏麻醉方案对术后并发症及医疗费用的影响。  

Objectives of Study:

1)Aim to investigate the effect of precision cardiac anesthesia on pneumonia after cadiovascular surgery in adults; 2)To investigate the effect of precision cardiac anesthesia on postoperative complications and health care costs.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1) 年龄≥18岁;
2) 择期心血管手术的患者。

Inclusion criteria

1)Aged >= 18 years;
2)Patients undergoing elective cardiovascular surgery.

排除标准:

1) 药物和酒精滥用史者,全身麻醉药物过敏史者;
2) 严重肝、肾功能不全(Child-Pugh C级及以上,术前接受肾脏替代治疗者);
3) 术前需要机械通气支持或术前已诊断为肺炎的患者;
4) 术前一个月内出现全身或局部感染;
5) 感染性心内膜炎的患者;
6) 术前一个月内使用抗生素、糖皮质激素治疗的患者;
7) 拒绝参加本研究或其他研究者认为不适宜入选的情况(需注明具体原因)。

Exclusion criteria:

1) Previous history of drug and alcohol abuse,allergy to general anesthetics;
2) Severe hepatic insufficiency (Child-Pugh grades C),Severe renal insufficiency (requirement of renal replacement therapy);
3) Preoperative mechanical ventilation support or diagnosed with pneumonia before surgery;
4) Local or systemic Infection (within one month before surgery);
5) Patients with infective endocarditis;
6) Drug history of antibiotics and glucocorticoids (within one month before surgery);
7) Any other conditions that are considered unsuitable for study participation.

研究实施时间:

Study execute time:

From 2019-09-25 00:00:00 To 2021-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-09-25 00:00:00 To 2021-08-31 00:00:00  

干预措施:

Interventions:

组别:

对照组

样本量:

143

Group:

control group

Sample size:

干预措施:

传统心脏麻醉方案

干预措施代码:

Intervention:

conventional cardiac anesthesia

Intervention code:

组别:

试验组

样本量:

143

Group:

experimental group

Sample size:

干预措施:

精准心脏麻醉方案

干预措施代码:

Intervention:

precision cardiac anesthesia

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

西城区 

Country:

China 

Province:

Beijing 

City:

Xicheng District 

单位(医院):

中国医学科学院阜外医院 

单位级别:

三甲 

Institution
hospital:

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后肺炎

指标类型:

主要指标

Outcome:

incidence of postoperative pneumonia

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

机械通气时间

指标类型:

次要指标

Outcome:

duration of mechanical ventilation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

ICU 时间

指标类型:

次要指标

Outcome:

ICU Length of stay

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后住院时间

指标类型:

次要指标

Outcome:

postoperative hospital length of stay

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院费用

指标类型:

次要指标

Outcome:

hospital costs

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后30天死亡率

指标类型:

次要指标

Outcome:

thirty day mortality

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由统计学人员采用中央随机系统产生随机数进行随机分配入组。

Randomization Procedure (please state who generates the random number sequence and by what method):

The statistician use the central randomization system to generate random numbers for random allocation

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

该临床试验对受试患者、实施手术的外科医生、术后负责患者治疗的 ICU 医生、随访研究人员及数据统计人员均设盲。

Blinding:

Double blind

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

中国医学科学院阜外医院

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic data capture

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2019-09-07 10:30:23